Transforming growth factor-beta 1, 2, 3 and receptor type I and II in diabetic foot ulcers (Q44024457)

29 November 2017

title

Transforming growth factor-beta 1, 2, 3 and receptor type I and II in diabetic foot ulcers (English)

1 reference

29 November 2017

Jude EB

1

1 reference

29 November 2017

Blakytny R

2

1 reference

29 November 2017

Bulmer J

3

1 reference

29 November 2017

Boulton AJ

4

1 reference

29 November 2017

Ferguson MW

5

1 reference

29 November 2017

publication date

1 June 2002

1 reference

29 November 2017

1 reference

29 November 2017

volume

19

1 reference

29 November 2017

issue

6

1 reference

29 November 2017

page(s)

440-447

1 reference

The role of growth factors in wound healing

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00692.X

Transforming growth factor beta s and wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00692.X

Lack of insulin-like growth factor 1 (IGF1) in the basal keratinocyte layer of diabetic skin and diabetic foot ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00692.X

Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00692.X

Mitogenic effect of transforming growth factor beta 1 on human fibroblasts involves the induction of platelet-derived growth factor alpha receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00692.X

Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00692.X

Control of scarring in adult wounds by neutralising antibody to transforming growth factor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00692.X

One systemic administration of transforming growth factor-beta 1 reverses age- or glucocorticoid-impaired wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00692.X

Transforming growth factor beta reverses the glucocorticoid-induced wound-healing deficit in rats: possible regulation in macrophages by platelet-derived growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00692.X

Immunocytochemical localization and serologic detection of transforming growth factor beta 1. Association with type I procollagen and inflammatory cell markers in diffuse and limited systemic sclerosis, morphea, and Raynaud's phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00692.X

Direct evidence for spatial and temporal regulation of transforming growth factor beta 1 expression during cutaneous wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00692.X

10.1046/J.1464-5491.2002.00692.X

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference